Catch-Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial

Author:

De Benedetti Fabrizio1,Brunner Hermine2,Ruperto Nicolino3,Schneider Rayfel4,Xavier Ricardo5,Allen Roger6,Brown Diane E.7,Chaitow Jeffrey8,Pardeo Manuela1,Espada Graciela9,Gerloni Valeria10,Myones Barry L.11,Frane James W.12,Wang Jianmei13,Lipman Terri H.14,Bharucha Kamal N.12,Martini Alberto15,Lovell Daniel2,

Affiliation:

1. IRCCS Ospedale Pediatrico Bambino Gesù; Rome Italy

2. University of Cincinnati and Cincinnati Children's Hospital Medical Center; Cincinnati Ohio

3. Istituto Giannina Gaslini; Genoa Italy

4. Hospital for Sick Children and University of Toronto, Toronto; Ontario Canada

5. Hospital de Clinicas de Porto Alegre and Universidade Federal do Rio Grande do Sul; Porto Alegre Brazil

6. Royal Children's Hospital, Melbourne; Victoria Australia

7. Children's Hospital of Los Angeles and University of Southern California; Los Angeles

8. Children's Hospital Westmead, Westmead; New South Wales Australia

9. Hospital de Niños Ricardo Gutierrez; Buenos Aires Argentina

10. Istituto Gaetano Pini; Milan Italy

11. Texas Children's Hospital and Baylor College of Medicine; Houston Texas

12. Genentech; South San Francisco California

13. Roche Products Ltd.; Welwyn Garden City UK

14. University of Pennsylvania School of Nursing; Philadelphia

15. Istituto Giannina Gaslini and Università di Genova; Genoa Italy

Funder

Bristol-Myers Squibb

Centocor

GlaxoSmithKline

Novartis

Pfizer

Roche

Sanofi-Aventis

Schwarz Biosciences

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Reference35 articles.

1. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001;Petty;J Rheumatol,2004

2. Juvenile idiopathic arthritis;Ravelli;Lancet,2007

3. Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome;Woo;Nat Clin Pract Rheumatol,2006

4. Systemic onset juvenile rheumatoid arthritis;Schneider;Baillieres Clin Rheumatol,1998

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3